Senior Industry Advisor - Healthcare&Life Sciences, Zürich (Kreis 11)

Switzerland's pharmaceutical and medtech sector generates some of the world's most sophisticated M&A transactions. Your operational experience inside these organisations is what separates a credible advisor from a generic one.

ONEtoONE is a global network of 120+ independent M&A advisors in 55 countries. Our Senior Industry Advisors in Switzerland co-advise on transactions where sector precision and executive-level relationships are the defining factors— particularly in pharma, specialty pharma, medtech, and diagnostics.

What you get

Competitive revenue share on mandates you originate or where your sector expertise drives the process

Active Swiss and DACH healthcare deal flow: pharma, specialty chemicals, medtech, diagnostics, CROs

Institutional brand: operate as a Senior Advisor of a recognised global investment banking platform

200+ advisors in 55 countries— connecting Swiss healthcare companies with global strategic buyers and financial sponsors

Full execution support: analyst team, sector databases, CIMs, and pitch materials provided

Who you are

Former C-suite executive (CEO, CFO, CMO, BD Director) of a Swiss or international pharma or medtech company— 20+ years in the sector

Deep network within the Swiss pharmaceutical, biotech, medtech, or private equity community

Experience with M&A, licensing, divestments, or strategic transactions from the operator's side

Currently independent, board-active, or defining your next advisory chapter

Switzerland's healthcare M&A rewards discretion, precision, and genuine insider knowledge. ONEtoONE Senior Industry Advisors bring all three.

#J-18808-Ljbffr